Synthetic biodegradable polyesters for implantable controlled-release devices

被引:14
作者
Pothupitiya, Jinal U. [1 ,2 ,3 ,4 ]
Zheng, Christy [1 ,2 ,3 ,4 ]
Saltzman, W. Mark [1 ,2 ,3 ,4 ]
机构
[1] Yale Univ, Dept Biomed Engn, New Haven, CT USA
[2] Yale Univ, Dept Chem & Environm Engn, New Haven, CT USA
[3] Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT USA
[4] Yale Univ, Dept Dermatol, New Haven, CT 06520 USA
关键词
Polyester; controlled release; biodegradable implants; polymeric implants; RING-OPENING POLYMERIZATION; SITU FORMING IMPLANTS; DRUG-DELIVERY; SUSTAINED-RELEASE; MECHANICAL-PROPERTIES; FIBROUS CAPSULE; EPSILON-CAPROLACTONE; HORMONE ANALOG; SOLUTE RELEASE; IN-VITRO;
D O I
10.1080/17425247.2022.2131768
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction Implantable devices can be designed to release drugs to localized regions of tissue at sustained and reliable rates. Advances in polymer engineering have led to the design and development of drug-loaded implants with predictable, desirable release profiles. Biodegradable polyesters exhibit chemical, physical, and biological properties suitable for developing implants for pain management, cancer therapy, contraception, antiviral therapy, and other applications. Areas covered This article reviews the use of biodegradable polyesters for drug-loaded implants by discussing the properties of commonly used polymers, techniques for implant formulation and manufacturing, mechanisms of drug release, and clinical applications of implants as drug delivery devices. Expert opinion Drug delivery implants are unique systems for safe and sustained drug release, providing high bioavailability and low toxicity. Depending on the implant design and tissue site of deployment, implants can offer either localized or systemic drug release. Due to the long history of use of degradable polyesters in medical devices, polyester-based implants represent an important class of controlled release technologies. Further, polyester-based implants are the largest category of drug delivery implants to reach the point of testing in humans or approval for human use.
引用
收藏
页码:1351 / 1364
页数:14
相关论文
共 186 条
[1]   ZOLADEX - A SUSTAINED-RELEASE, MONTHLY LUTEINIZING-HORMONE-RELEASING HORMONE ANALOG FOR THE TREATMENT OF ADVANCED PROSTATE-CANCER [J].
AHMANN, FR ;
CITRIN, DL ;
DEHAAN, HA ;
GUINAN, P ;
JORDAN, VC ;
KREIS, W ;
SCOTT, M ;
TRUMP, DL .
JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (06) :912-917
[2]   Applications of Electrospun Drug-Eluting Nanofibers in Wound Healing: Current and Future Perspectives [J].
Akombaetwa, Nakamwi ;
Bwanga, Alick ;
Makoni, Pedzisai Anotida ;
Witika, Bwalya A. .
POLYMERS, 2022, 14 (14)
[3]   Polymer-Based Electrospun Nanofibers for Biomedical Applications [J].
Al-Enizi, Abdullah M. ;
Zagho, Moustafa M. ;
Elzatahry, Ahmed A. .
NANOMATERIALS, 2018, 8 (04)
[4]   Factors affecting the degradation and drug-release mechanism of poly(lactic acid) and poly[(lactic acid)-co-(glycolic acid)] [J].
Alexis, F .
POLYMER INTERNATIONAL, 2005, 54 (01) :36-46
[5]   THE ROLE OF THE FIBROUS CAPSULE IN THE FUNCTION OF IMPLANTED DRUG-POLYMER SUSTAINED-RELEASE SYSTEMS [J].
ANDERSON, JM ;
NIVEN, H ;
PELAGALLI, J ;
OLANOFF, LS ;
JONES, RD .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1981, 15 (06) :889-902
[6]  
[Anonymous], 2017, DRUG APPR PACK ZILRE
[7]  
[Anonymous], 2021, FDA approves first extended-release, injectable drug regimen for adults living with HIV
[8]   PREPARATION AND PROPERTIES OF POLY(VALEROLACTONE) [J].
AUBIN, M ;
PRUDHOMME, RE .
POLYMER, 1981, 22 (09) :1223-1226
[9]  
Azevedo HS, 2005, BIODEGRADABLE SYSTEMS IN TISSUE ENGINEERING AND REGENERATIVE MEDICINE, P177
[10]   Development and characterization of composition-equivalent formulations to the Sandostatin LAR® by the solvent evaporation method [J].
Beig, Avital ;
Feng, Linglin ;
Walker, Jennifer ;
Ackermann, Rose ;
Hong, Justin K. Y. ;
Li, Tinghui ;
Wang, Yan ;
Schwendeman, Steven P. .
DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2022, 12 (03) :695-707